MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2009-04, Vol.23 (4), p.801-803
Hauptverfasser:	Stralen, Ev, Leguit, R J, Begthel, H, Michaux, L, Buijs, A, Lemmens, H, Scheiff, J M, Doyen, C, Pierre, P, Forget, F, Clevers, H C, Bast, BJEG
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Biomarkers, Tumor Cancer Research Chromosomes, Human, Pair 14 Chromosomes, Human, Pair 20 Critical Care Medicine Diagnostic immunohistochemistry Female Genetic aspects Hematologic and hematopoietic diseases Hematology Humans Immunodeficiencies. Immunoglobulinopathies Immunoglobulinopathies Immunohistochemistry Immunopathology Intensive Internal Medicine letter-to-the-editor Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis MafB Transcription Factor - analysis Male Medical sciences Medicine Medicine & Public Health Middle Aged Multiple myeloma Multiple Myeloma - diagnosis Multiple Myeloma - genetics Oncogene Proteins - analysis Oncogenes Oncology Oncoproteins Physiological aspects Prognosis Risk factors Translocation, Genetic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!